Placental Leucine Aminopeptidase as a Potential Specific Urine Biomarker for Invasive Ovarian Cancer.
Placental Leucine Aminopeptidase as a Potential Specific Urine Biomarker for Invasive Ovarian Cancer.
复制标题
DOI:
10.3390/jcm11010222
复制
发表时间:
2021-12-31
影响因子:
3.9
通讯作者:
Shibata K
中科院分区:
文献类型:
--
作者:
Matsukawa T;Mizutani S;Matsumoto K;Kato Y;Yoshihara M;Kajiyama H;Shibata K
Background: A non-invasive and sensitive biomarker for the detection of ovarian cancer (OvCa) is lacking. We aim to investigate if urinary placental leucine aminopeptidase (P-LAP) can serve as a reliable biomarker for OvCa. Methods: P-LAP activity was measured using a LAP assay kit (Serotech Co., Ltd., Sapporo, Japan) in the urine of 22 patients with benign or borderline malignant ovarian tumors and 18 patients with OvCa. In this assay, L-methionine was added at 20 mM because P-LAP is functional, but other aminopeptidases are inhibited at this dose of L-methionine. Results: The mean urinary P-LAP activity was significantly higher in the OvCa group than in the benign or borderline malignant tumor group. When the cut-off value of P-LAP was determined as 11.00 U/L, its sensitivity and specificity for differentiating invasive cancer were 77.8% and 95.5%, respectively. Conclusion: Although the usefulness of this test should be confirmed in a larger cohort of cases and controls, our study is the first to highlight the importance of urinary P-LAP as a biomarker for OvCa.
登录
查看更多内容
影响因子:
3.2
作者:
Kobayashi, H;Nomura, S;Mizutani, S
通讯作者:
Mizutani, S
影响因子:
1.9
作者:
Nagasaka, T;Nomura, S;Mizutani, S
通讯作者:
Mizutani, S
影响因子:
--
作者:
Larrinaga, Gorka;Lopez, Jose I.;Varona, Adolfo
通讯作者:
Varona, Adolfo
影响因子:
4.7
作者:
Shibata, K;Kajiyama, H;Kikkawa, F
通讯作者:
Kikkawa, F
DOI:
10.1007/978-1-4939-6934-0_19
发表时间:
2017
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
Fennelly C;Amaravadi RK
通讯作者:
Amaravadi RK